Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin
Jung Seok Lee, Patrick Han, Rabib Chaudhury, Shihan N. Khan, Sean Bickerton, Michael McHugh, Hyun Bong Park, Alyssa Siefert, Gerald Rea, José M. Carballido, David A. Horwitz, Jason M. Criscione, Karlo Perica, Robert Samstein, Ragy Ragheb, Dongin Kim, Tarek M. Fahmy
Topics & Concepts
NanocarriersBile acidInsulinUrsodeoxycholic acidChemistryInternal medicineEndocrinologyG protein-coupled bile acid receptorBioavailabilityPharmacologyType 1 diabetesDiabetes mellitusMedicineDrugPancreatic function and diabetesDiabetes Management and ResearchAdvanced Drug Delivery Systems